Clinical trial
Safety, Efficacy and Acceptability of Flavocoxid (Limbrel)A Pilot Study
NCT00303017 · Primus Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00303017 |
|---|---|
| Title | Safety, Efficacy and Acceptability of Flavocoxid (Limbrel)A Pilot Study |
| Official title | Safety, Efficacy and Acceptability of Flavocoxid (Limbrel) Compared With Naproxen in Subjects With Osteoarthritis of the Knee. A Pilot Study |
| Lead sponsor | Primus Pharmaceuticals, Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Osteoarthritis |
| Intervention type | Dietary Supplement, Drug |
| Interventions | flavocoxid, Naproxen |
| Enrollment | 60 |
| Start date | Mar 1, 2006 |
| Primary completion | Jul 1, 2006 |
| Completion | Sep 1, 2006 |
| First posted | Mar 15, 2006 |
| Last update posted | Oct 21, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: